ACTC1 Gene - Actin Alpha Cardiac Muscle 1

Key sarcomeric gene in cardiac muscle contraction and cardiomyopathy

Gene Information Card

Symbol ACTC1
Full Name Actin Alpha Cardiac Muscle 1
Gene Type Protein coding
Chromosomal Location 15q14
NCBI Gene ID 70 ncbi.nlm.nih.gov/gene/70
Ensembl ID ENSG00000159251
UniProt ID P68032
OMIM ID 102540
HGNC ID 143
Aliases ACTC, ASD5, CMD1R, CMH11, LVNC4

Description

The ACTC1 gene encodes cardiac muscle alpha-actin, a major component of the sarcomeric thin filament in cardiac muscle. This protein is essential for cardiac contractility and force generation. Mutations in ACTC1 are associated with various cardiomyopathies, including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and left ventricular noncompaction (LVNC).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Dilated Cardiomyopathy 1R (CMD1R) Impaired actin-myosin interaction due to missense mutations reducing contractile force ClinVar, OMIM
Hypertrophic Cardiomyopathy 11 (CMH11) Dominant-negative or gain-of-function mutations increasing calcium sensitivity or sarcomere hypercontractility ClinVar, OMIM
Restrictive Cardiomyopathy Mutations altering actin dynamics leading to diastolic dysfunction ClinVar, OMIM
Left Ventricular Noncompaction 4 (LVNC4) Disrupted sarcomere assembly during development ClinVar, OMIM
Atrial Septal Defect 5 (ASD5) Developmental defects in cardiac morphogenesis OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 127.6 High
Skeletal Muscle 2.1 Low
Esophagus 0.8 Not detected
Liver 0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
Cardiomyocytes (iPS-derived) 150.2 High expression
Skeletal muscle myoblasts 3.5 Low expression
HEK293 0.0 Not expressed
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Ala295Ser Missense Rare Associated with HCM; increased calcium sensitivity
p.Glu101Lys Missense Rare Associated with DCM; reduced actin polymerization
p.Met305Leu Missense Rare Associated with RCM; altered thin filament regulation
p.Arg312His Missense Rare Associated with LVNC; impaired sarcomere assembly
Mutation functional classification

Loss of Function (LOF)

Missense mutations that impair actin polymerization or reduce contractile force (e.g., p.Glu101Lys) are loss-of-function and linked to DCM.

Gain of Function (GOF)

Mutations that increase calcium sensitivity or enhance actin-myosin interaction (e.g., p.Ala295Ser) are gain-of-function and linked to HCM.

Dominant Negative (DN)

Mutations that incorporate mutant actin into sarcomeres and disrupt normal filament function (e.g., p.Met305Leu) act via dominant-negative mechanism.

Gene Ontology (GO)

• GO:0005200 - structural constituent of cytoskeleton • GO:0005515 - protein binding
• GO:0005524 - ATP binding • GO:0005856 - cytoskeleton
• GO:0015629 - actin cytoskeleton • GO:0030049 - muscle filament sliding
• GO:0060048 - cardiac muscle contraction

Pathways

Cardiac muscle contraction (KEGG: hsa04260)
Hypertrophic cardiomyopathy (KEGG: hsa05410)
Dilated cardiomyopathy (KEGG: hsa05414)
Actin cytoskeleton regulation (KEGG: hsa04810)

Protein Summary

Cardiac muscle alpha-actin (42 kDa) is a highly conserved protein that forms the core of the thin filament in cardiac sarcomeres. It polymerizes into filamentous actin (F-actin) and interacts with myosin, tropomyosin, and troponin to generate contractile force. The protein is encoded by ACTC1 and is expressed almost exclusively in the heart. Mutations disrupt sarcomere function, leading to a spectrum of cardiomyopathies.

Related Products

Product name Cat.No. Species Gene ID
ACTC1 Knockout HEK293 Cell Line EDJ-KQ3854 Human 70 Details Get a Quote
ACTC1 Knockout HeLa Cell Line EDJ-KQ26043 Human 70 Details Get a Quote
ACTC1 Knockout A-549 Cell Line EDJ-KQ61023 Human 70 Details Get a Quote
ACTC1 Knockout HCT 116 Cell Line EDJ-KQ69498 Human 70 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: